1. Home
  2. STXS vs KDP Comparison

STXS vs KDP Comparison

Compare STXS & KDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • KDP
  • Stock Information
  • Founded
  • STXS 1990
  • KDP 1981
  • Country
  • STXS United States
  • KDP United States
  • Employees
  • STXS N/A
  • KDP N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KDP Beverages (Production/Distribution)
  • Sector
  • STXS Health Care
  • KDP Consumer Staples
  • Exchange
  • STXS Nasdaq
  • KDP Nasdaq
  • Market Cap
  • STXS 151.3M
  • KDP N/A
  • IPO Year
  • STXS 2004
  • KDP 1993
  • Fundamental
  • Price
  • STXS $2.18
  • KDP $34.14
  • Analyst Decision
  • STXS
  • KDP Strong Buy
  • Analyst Count
  • STXS 0
  • KDP 15
  • Target Price
  • STXS N/A
  • KDP $39.33
  • AVG Volume (30 Days)
  • STXS 285.8K
  • KDP 15.0M
  • Earning Date
  • STXS 05-12-2025
  • KDP 04-24-2025
  • Dividend Yield
  • STXS N/A
  • KDP 2.70%
  • EPS Growth
  • STXS N/A
  • KDP N/A
  • EPS
  • STXS N/A
  • KDP 1.10
  • Revenue
  • STXS $26,918,000.00
  • KDP $15,518,000,000.00
  • Revenue This Year
  • STXS $25.90
  • KDP $6.14
  • Revenue Next Year
  • STXS $60.57
  • KDP $3.99
  • P/E Ratio
  • STXS N/A
  • KDP $30.98
  • Revenue Growth
  • STXS 0.55
  • KDP 3.94
  • 52 Week Low
  • STXS $1.54
  • KDP $30.12
  • 52 Week High
  • STXS $2.72
  • KDP $38.28
  • Technical
  • Relative Strength Index (RSI)
  • STXS 66.61
  • KDP 47.01
  • Support Level
  • STXS $1.93
  • KDP $33.82
  • Resistance Level
  • STXS $2.07
  • KDP $34.42
  • Average True Range (ATR)
  • STXS 0.09
  • KDP 0.66
  • MACD
  • STXS 0.03
  • KDP -0.12
  • Stochastic Oscillator
  • STXS 94.05
  • KDP 26.73

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: